HIMS & HERS HEALTH INC (HIMS) Stock Price & Overview

NYSE:HIMS • US4330001060

Current stock price

24.88 USD
+0.11 (+0.44%)
At close:
24.6974 USD
-0.18 (-0.73%)
After Hours:

The current stock price of HIMS is 24.88 USD. Today HIMS is up by 0.44%. In the past month the price increased by 52.64%. In the past year, price decreased by -28.4%.

HIMS Key Statistics

52-Week Range13.74 - 70.43
Current HIMS stock price positioned within its 52-week range.
1-Month Range13.74 - 27.54
Current HIMS stock price positioned within its 1-month range.
Market Cap
5.671B
P/E
48.78
Fwd P/E
45.56
EPS (TTM)
0.51
Dividend Yield
N/A

HIMS Stock Performance

Today
+0.44%
1 Week
+12.27%
1 Month
+52.64%
3 Months
-30.03%
Longer-term
6 Months -56.97%
1 Year -28.40%
2 Years +60.83%
3 Years +150.81%
5 Years +88.06%
10 Years N/A

HIMS Stock Chart

HIMS & HERS HEALTH INC / HIMS Daily stock chart

HIMS Technical Analysis

ChartMill assigns a technical rating of 2 / 10 to HIMS. When comparing the yearly performance of all stocks, HIMS is a bad performer in the overall market: 88.74% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating

HIMS Fundamental Analysis

ChartMill assigns a fundamental rating of 4 / 10 to HIMS. HIMS has an average financial health and profitability rating.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

HIMS Earnings

On February 23, 2026 HIMS reported an EPS of 0.08 and a revenue of 617.82M. The company beat EPS expectations (71.14% surprise) and missed revenue expectations (-2.18% surprise).

Next Earnings DateMay 4, 2026
Last Earnings DateFeb 23, 2026
PeriodQ4 / 2025
EPS Reported$0.08
Revenue Reported617.818M
EPS Surprise 71.14%
Revenue Surprise -2.18%

HIMS Forecast & Estimates

21 analysts have analysed HIMS and the average price target is 30 USD. This implies a price increase of 20.59% is expected in the next year compared to the current price of 24.88.

For the next year, analysts expect an EPS growth of 7.08% and a revenue growth 16.86% for HIMS


Analysts
Analysts54.29
Price Target30 (20.58%)
EPS Next Y7.08%
Revenue Next Year16.86%

HIMS Groups

Sector & Classification

HIMS Financial Highlights

Over the last trailing twelve months HIMS reported a non-GAAP Earnings per Share(EPS) of 0.51. The EPS decreased by -5.56% compared to the year before.


Income Statements
Revenue(TTM)2.35B
Net Income(TTM)128.37M
Industry RankSector Rank
PM (TTM) 5.47%
ROA 5.96%
ROE 23.73%
Debt/Equity 1.8
Chartmill High Growth Momentum
EPS Q2Q%-27.27%
Sales Q2Q%28.41%
EPS 1Y (TTM)-5.56%
Revenue 1Y (TTM)59%

HIMS Ownership

Ownership
Inst Owners85.66%
Shares227.94M
Float204.62M
Ins Owners6.6%
Short Float %41.52%
Short Ratio2.41

HIMS Latest News, Press Relases and Analysis

HIMS Competitors/Peers

The largest stocks on the US markets in the "Health Care Services" sub-industry
Full List
SymbolCompany NameTechnical RatingFundamental RatingFPEMarket Cap
CVS CVS HEALTH CORP10.4696.853B
CI THE CIGNA GROUP8.5970.413B
BTSGU BRIGHTSPRING HEALTH SERV - BTSG 6 3/4 02/01/2794.5824.843B
DGX QUEST DIAGNOSTICS INC18.5221.941B
LH LABCORP HOLDINGS INC14.6121.737B
GH GUARDANT HEALTH INC N/A11.214B
DVA DAVITA INC10.4810.068B
BTSG BRIGHTSPRING HEALTH SERVICES28.167.415B
CHE CHEMED CORP16.435.534B
RDNT RADNET INC80.574.805B
OPCH OPTION CARE HEALTH INC15.414.582B
HNGE HINGE HEALTH INC-A22.453.542B

About HIMS

Company Profile

HIMS logo image Hims & Hers Health, Inc. operates a telehealth consultation platform. The company is headquartered in San Francisco, California and currently employs 2,442 full-time employees. The company went IPO on 2019-09-09. Its platform includes access to a provider network, a clinically focused electronic medical record system, digital prescriptions, cloud pharmacy fulfillment, and personalization capabilities. Its digital platform enables access to treatments for a range of chronic conditions, including those related to sexual health, hair loss, dermatology, mental health, and weight loss. The company connects patients to licensed healthcare professionals who can prescribe medications when appropriate and prescriptions are fulfilled online through licensed pharmacies on a subscription basis. The company also offers access to a range of health and wellness products designed to meet individual needs, which can include curated prescription and non-prescription products. Through its mobile applications, consumers can access a range of educational programs, wellness content, and other services.

Company Info

IPO: 2019-09-09

HIMS & HERS HEALTH INC

2269 Chestnut St, #523

San Francisco CALIFORNIA 94123 US

CEO: Andrew Dudum

Employees: 2442

HIMS Company Website

HIMS Investor Relations

Phone: 18003166660

HIMS & HERS HEALTH INC / HIMS FAQ

What does HIMS & HERS HEALTH INC do?

Hims & Hers Health, Inc. operates a telehealth consultation platform. The company is headquartered in San Francisco, California and currently employs 2,442 full-time employees. The company went IPO on 2019-09-09. Its platform includes access to a provider network, a clinically focused electronic medical record system, digital prescriptions, cloud pharmacy fulfillment, and personalization capabilities. Its digital platform enables access to treatments for a range of chronic conditions, including those related to sexual health, hair loss, dermatology, mental health, and weight loss. The company connects patients to licensed healthcare professionals who can prescribe medications when appropriate and prescriptions are fulfilled online through licensed pharmacies on a subscription basis. The company also offers access to a range of health and wellness products designed to meet individual needs, which can include curated prescription and non-prescription products. Through its mobile applications, consumers can access a range of educational programs, wellness content, and other services.


What is the stock price of HIMS & HERS HEALTH INC today?

The current stock price of HIMS is 24.88 USD. The price increased by 0.44% in the last trading session.


Does HIMS stock pay dividends?

HIMS does not pay a dividend.


How is the ChartMill rating for HIMS & HERS HEALTH INC?

HIMS has a ChartMill Technical rating of 2 out of 10 and a ChartMill Fundamental rating of 4 out of 10.


Can you provide the PE ratio for HIMS stock?

The PE ratio for HIMS & HERS HEALTH INC (HIMS) is 48.78. This is based on the reported non-GAAP earnings per share of 0.51 and the current share price of 24.88 USD.


Can you provide the upcoming earnings date for HIMS & HERS HEALTH INC?

HIMS & HERS HEALTH INC (HIMS) will report earnings on 2026-05-04.